Joint Symposium with the ESC: The pulmonary circulation in the heart failure syndrome

24 June 2021

A PVRI 2022 Digital webinar

Presentations 

  • The right ventricle in HFpEF, Marco Guazzi
  • Genetic aspects in group2 PH, Mark Toshner 
  • Exercise haemodynamics in heart failure: what can we learn from invasive CPET? Gabor Kovacs 
  • Systemic consequences and interorgan cross-talk in heart failure and PH, Stephan Rosenkranz
  • The natriuretic peptide Clearance receptor selectively causes right ventricular dysfunction in a model of pulmonary hypertension and heart failure with preserved ejection fraction, Vineet Agrawal 
  • N-Lysine methyltransferase Smyd2-mediated HIF-1A stabilization plays a protective role in RV hypertrophy, Swathi Veeroju

Speakers & moderators

Marco Guazzi, University of Milan, Italy
Mark Toshner, University of Cambridge, UK
Gabor Kovacs, University of Vienna, Austria
Stephan Rosenkranz, University of Cologne, Germany
Vineet Agrawal, Vanderbilt University Medical Center, USA
Swathi Veeroju, Justus Liebig University Giessen, Germany
Share:

Other materials on this topic

3 December 2025

Improvement in Right Ventricular Function and Pulmonary Pressures in Patients With Severe Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction Treated With Sacubitril-Valsartan

Pulmonary hypertension (PH) significantly impacts outcomes in heart failure with preserved ejection fraction (HFpEF), especially with right ventricular dysfunction (RVD), yet effective treatments are limited. This study retrospectively evaluated sacubitril-valsartan's effects on pulmonary pressures, RV function, and clinical outcomes in 20 severe HFpEF-PH patients. 

Pulmonary Circulation
26 October 2025

Empiric Pulmonary Arterial Compliance Reflects the Resistance-Compliance Relationship and Predicts Mortality in Pulmonary Hypertension

The resistance–compliance (RC) relationship between pulmonary vascular resistance (PVR) and pulmonary arterial compliance (PAC) provides an integrative measure of global right ventricular (RV) afterload. However, debate persists regarding the clinical utility of PAC calculated using the empiric formula (PACempiric), and the ideal method for calculating PAC. 

Pulmonary Circulation
24 April 2025

Transcriptional Signatures of the Right Ventricle in End-Stage Heart Failure

The molecular mechanisms driving right ventricular (RV) adaptation to stress and failure in end-stage heart failure (HF) are largely unknown. We aimed to characterize myocardial transcriptional changes in the RV caused by left sided HF and comparing RV compensation to failure. 

Pulmonary Circulation